Atrial fibrillation genetic risk differentiates cardioembolic stroke from other stroke subtypes

Sara L. Pulit, Lu-Chen Weng, Patrick F. McArdle, Ludovic Trinquart, Seung Hoan Choi, Braxton D. Mitchell, Jonathan Rosand, Paul I. W. de Bakker, Emelia J. Benjamin, Patrick T. Ellinor, Steven J. Kittner, Steven A. Lubitz, Christopher D. Anderson, Ingrid E. Christophersen, Michiel Rienstra, Carolina Roselli, Xiaoyan Yin, Bastiaan Geelhoed, John Barnard, Honghuang LinDan E. Arking, Albert Smith, Christine M. Albert, Mark Chaffin, Nathan R. Tucker, Molong Li, Derek Klarin, Nathan A. Bihlmeyer, Siew-Kee Low, Peter E. Weeke, Martina Muller-Nurasyid, J. Gustav Smith, Jennifer A. Brody, Maartje N. Niemeijer, Marcus Dorr, Stella Trompet, Jennifer Huffman, Stefan Gustafsson, Claudia Schurmann, Marcus E. Kleber, Leo-Pekka Lyytikainen, Ilkka Seppala, Rainer Malik, Andrea R. V. R. Horimoto, Marco Perez, Juha Sinisalo, Stefanie Aeschbacher, Sebastien Theriault, Lin Y. Chen, Julie Staals, Atrial Fibrillation Genetics Conso; Int Stroke Genetics Consortium

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Article number293
Number of pages8
JournalNeurology. Genetics
Volume4
Issue number6
DOIs
Publication statusPublished - 1 Dec 2018

Keywords

  • ISCHEMIC-STROKE
  • CAUSATIVE CLASSIFICATION
  • LIFETIME RISK
  • EPIDEMIOLOGY
  • ASSOCIATION
  • PREVENTION
  • VARIANTS
  • ASPIRIN
  • BURDEN

Cite this